KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Inventory (2017 - 2025)

Historic Inventory for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $1.7 billion.

  • Elanco Animal Health's Inventory rose 465.69% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 465.69%. This contributed to the annual value of $1.6 billion for FY2024, which is 927.95% down from last year.
  • Elanco Animal Health's Inventory amounted to $1.7 billion in Q3 2025, which was up 465.69% from $1.7 billion recorded in Q2 2025.
  • Elanco Animal Health's Inventory's 5-year high stood at $1.7 billion during Q4 2023, with a 5-year trough of $1.3 billion in Q2 2022.
  • Moreover, its 5-year median value for Inventory was $1.6 billion (2025), whereas its average is $1.5 billion.
  • Over the last 5 years, Elanco Animal Health's Inventory had its largest YoY gain of 3974.48% in 2021, and its largest YoY loss of 1340.55% in 2021.
  • Over the past 5 years, Elanco Animal Health's Inventory (Quarter) stood at $1.4 billion in 2021, then grew by 12.18% to $1.5 billion in 2022, then grew by 12.81% to $1.7 billion in 2023, then decreased by 9.28% to $1.6 billion in 2024, then rose by 8.51% to $1.7 billion in 2025.
  • Its Inventory was $1.7 billion in Q3 2025, compared to $1.7 billion in Q2 2025 and $1.6 billion in Q1 2025.